LAMP3 and metabolic dysfunction-associated steatohepatitis: For instance, in nonalcoholic fatty liver disease (NAFLD), the overexpression of LAMP3 substantially increased the lipid accumulation of hepatocytes (20), in our study, we also found that the expression of LAMP3 in the liver of NASH patients was significantly higher than that in healthy controls.